Literature DB >> 17713360

An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases.

Yuko Kawakami1, Kenji Yumoto, Toshiaki Kawakami.   

Abstract

BACKGROUND: Atopic dermatitis is a chronic or chronically relapsing, pruritic inflammatory skin disease. The incidence of atopic dermatitis has dramatically increased during the past three decades in industrialized countries. We attempted to develop an improved method to induce an animal model of atopic dermatitis and to use it to evaluate the efficacy of a Tec family kinase inhibitor.
METHODS: We treated dermatitis-prone inbred mice, NC/Nga, by repetitive epicutaneous applications of a house dust mite allergen and staphylococcal enterotoxin B to induce atopic dermatitis-like skin lesions.
RESULTS: We established a highly efficient protocol to induce skin lesions in NC/Nga mice, which were histologically and immunologically similar to human atopic dermatitis. Similar to human patients, serum IgE levels were increased in dermatitis-induced mice. Consistent with the proposed roles of infiltrated immune cells in the pathogenesis of human atopic dermatitis, skin lesions were treatable with terreic acid, an inhibitor of Tec family kinases, as well as dexamethasone.
CONCLUSIONS: We established a highly efficient, highly reproducible protocol to induce skin lesions in NC/Nga mice and successfully applied it to show the efficacy of terreic acid in treating skin lesions. This mouse model of atopic dermatitis will be useful to study the pathogenetic processes of atopic dermatitis and to evaluate the efficacy of drug candidates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713360     DOI: 10.2332/allergolint.O-07-486

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  22 in total

1.  Defective natural killer cell activity in a mouse model of eczema herpeticum.

Authors:  Yuko Kawakami; Tomoaki Ando; Jong-Rok Lee; Gisen Kim; Yu Kawakami; Tae Nakasaki; Manando Nakasaki; Kenji Matsumoto; Youn Soo Choi; Toshiaki Kawakami
Journal:  J Allergy Clin Immunol       Date:  2016-07-29       Impact factor: 10.793

2.  Protective murine and human monoclonal antibodies against eczema vaccinatum.

Authors:  Yoshiaki Tomimori; Yuko Kawakami; Megan M McCausland; Tomoaki Ando; Lilia Koriazova; Shinichiro Kato; Toshiaki Kawakami; Shane Crotty
Journal:  Antivir Ther       Date:  2011

3.  Topical application of a phospholipid mixture purified from pig lungs ameliorates 2,4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice.

Authors:  Jeong-Su Moon; Byung-Suk Jeon; Byung-Il Yoon; Seong-Hyun Choi; Chang-Jin Lim
Journal:  Mol Biol Rep       Date:  2011-07-20       Impact factor: 2.316

4.  Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasis.

Authors:  Thomas Marichal; Nicolas Gaudenzio; Sophie El Abbas; Riccardo Sibilano; Oliwia Zurek; Philipp Starkl; Laurent L Reber; Dimitri Pirottin; Jinah Kim; Pierre Chambon; Axel Roers; Nadine Antoine; Yuko Kawakami; Toshiaki Kawakami; Fabrice Bureau; See-Ying Tam; Mindy Tsai; Stephen J Galli
Journal:  J Clin Invest       Date:  2016-11-07       Impact factor: 14.808

Review 5.  Mast cells in atopic dermatitis.

Authors:  Toshiaki Kawakami; Tomoaki Ando; Miho Kimura; Bridget S Wilson; Yuko Kawakami
Journal:  Curr Opin Immunol       Date:  2009-10-14       Impact factor: 7.486

6.  Polyclonal IgE induces mast cell survival and cytokine production.

Authors:  Jun-ichi Kashiwakura; Yuko Kawakami; Keisuke Yuki; Dirk M Zajonc; Shunji Hasegawa; Yoshiaki Tomimori; Benjamin Caplan; Hirohisa Saito; Masutaka Furue; Hans C Oettgen; Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Allergol Int       Date:  2009-06-25       Impact factor: 5.836

7.  Genome-Wide Expression Profiles Drive Discovery of Novel Compounds that Reduce Binge Drinking in Mice.

Authors:  Laura B Ferguson; Angela R Ozburn; Igor Ponomarev; Pamela Metten; Matthew Reilly; John C Crabbe; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2017-12-18       Impact factor: 7.853

8.  Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c mice.

Authors:  Krisztina Szalai; Tamara Kopp; Anna Lukschal; Caroline Stremnitzer; Julia Wallmann; Philipp Starkl; Luc Vander Elst; Jean-Marie Saint-Remy; Isabella Pali-Schöll; Erika Jensen-Jarolim
Journal:  Exp Dermatol       Date:  2012-11       Impact factor: 3.960

9.  Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.

Authors:  Yuko Kawakami; Yoshiaki Tomimori; Kenji Yumoto; Shunji Hasegawa; Tomoaki Ando; Yutaka Tagaya; Shane Crotty; Toshiaki Kawakami
Journal:  J Exp Med       Date:  2009-05-25       Impact factor: 14.307

10.  Cytokinergic IgE Action in Mast Cell Activation.

Authors:  Heather J Bax; Anthony H Keeble; Hannah J Gould
Journal:  Front Immunol       Date:  2012-08-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.